Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET.

scientific article published in April 1987

Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/JCBFM.1987.50
P698PubMed publication ID3494029
P5875ResearchGate publication ID19665045

P50authorSteven H FerrisQ37369822
Barry ReisbergQ42412559
Mony J de LeonQ51766178
P2093author name stringMiller JD
Wolf AP
Kluger A
George AE
Sachs HJ
P2860cites workAlzheimer's disease: cell-specific pathology isolates the hippocampal formationQ34261572
Hemisphere differences in the acquisition and use of descriptive systemsQ38500632
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementiaQ48305999
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementiaQ48719942
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucoseQ48768629
Alzheimer's disease and the parietal lobeQ48773987
Patterns of declining memory.Q52261348
Pathological and positron emission tomographic correlations in Alzheimer's disease.Q53189657
The Global Deterioration Scale for assessment of primary degenerative dementiaQ57279034
Positron Emission Tomography in the Study of Aging and Senile DementiaQ57279043
P433issue2
P921main subjectAlzheimer's diseaseQ11081
P304page(s)248-251
P577publication date1987-04-01
P1433published inJournal of Cerebral Blood Flow & MetabolismQ14663525
P1476titleAbnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET.
P478volume7

Reverse relations

cites work (P2860)
Q48649929A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease
Q48491979Brain correlates of memory processes in patients with dementia of Alzheimer's type: a SPECT Activation Study
Q37645211Brain single photon emission computed tomography: newer activation and intervention studies
Q48958695Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function
Q40896821Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives
Q48607587Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease
Q34149288Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging
Q46067123Human brain metabolic responses to familiarity during lexical decision
Q38459906Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study
Q38461160Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type
Q36942866Parallel Distributed Processing and Neural Networks: Origins, Methodology and Cognitive Functions
Q36443614Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease.
Q48464716Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease
Q53187649Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.
Q36401418Translational research in central nervous system drug discovery
Q67488364Treatment of Alzheimer's disease
Q48474992Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism
Q41096506Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease
Q48622112d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain

Search more.